Folic acid and the prevention of birth defects

Annual Review of Nutrition

Volumn 16, Issue , 1996, Pages 73-97

  Butterworth Jr , C E ^a   Bendich, Adrianne ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b HOFFMANN LA ROCHE INC   (United States)

Author keywords

folate; homocyst(e)ine; multivitamins; periconceptional; vitamin B12

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; MULTIVITAMIN; PYRIDOXINE;

BIRTH DEFECT; CLEFT LIP; CLEFT PALATE; CLINICAL TRIAL; CONGENITAL HEART MALFORMATION; DIET SUPPLEMENTATION; DIETARY INTAKE; EMBRYO DEVELOPMENT; FOOD; HUMAN; LIMB MALFORMATION; NEURAL TUBE DEFECT; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; URINARY TRACT MALFORMATION;

EID: 9444228785     PISSN: 01999885     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.nu.16.070196.000445     Document Type: Review

References (91)

1. Adams MJ, Khoury MJ, Stevenson R, Haddow J, Knight G, et al. 1993. Mid-trimester serum methylmalonic acid as a risk marker for neural tube defects. Teratology 47:384
2. Bailey L. 1995. Folate requirements and dietary recommendations. In Folate in Health and Disease, ed. L Bailey, pp. 123-51. New York: Marcel Dekker
3. Bailey LB. 1995. Folate intake recommendations from a nutritional science perspective. Cereal Food World 40:63-66
4. Baker H, Thind IS, Frank O, DeAngelis B, Caterini H, et al. 1977. Vitamin levels in low-birth-weight newborn infants and their mothers. Am. J. Obstet. Gynecol. 129:521-24
5. Balen A. 1995. Minimal compliance with Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br. J. Obstet. Gynaecol. 102:171 (Letter)
6. Bendich A. 1994. Folic acid and prevention of neural tube birth defects: critical assessment of FDA proposals to increase folic acid intakes. J. Nutr. Educ. 26:294-99
7. Bendich A. 1991. Importance of vitamin status to pregnancy outcomes. In Micronutrients in Health and Disease Prevention, ed. A Bendich, CE Butterworth Jr, pp. 235-62. New York: Marcel Dekker
8. Biale Y, Lewenthal H. 1984. Effect of folic acid supplementation on congenital malformations due to anticonvulsive drugs. Eur. J. Obstet. Gynecol. 18:211-16
9. Block G, Abrams B. 1993. Vitamin and mineral status of woman of childbearing potential. Ann. NY Acad. Sci. 678:244-54
10. Botto LD, Khoury MJ, Mulinare J. 1995. Periconceptional use of vitamins and the prevention of conotruncal heart defects: evidence from a population-based case-control study. 4th Ann. Epidemic Intell. Serv. Conf., p. 56
11. Bower C, Stanley FJ. 1989. Dietary folate as a risk factor for neural tube defects: evidence from a case-control study in Western Australia. Med. J. Aust. 150:613-19
12. Bower C, Stanley FJ, Croft M, De Klerk NH. 1993. Absorption of pteroylpolyglutamates in mothers of infants with neural tube defects. Br. J. Nutr. 69:827-34
13. Bower C, Stanley FJ, Nicol DJ. 1993. Maternal folate status and the risk for neural tube defects. In Maternal Nutrition and Pregnancy Outcomes, ed. CL Keen, A Bendich, CC Willhite, pp. 146-55. New York: NY Acad. Sci.
14. Brattstrom LE, Israelsson B, Jeppsson JO, Hultberg BL. 1988. Folic acid - an innocuous means to reduce plasma homocysteine. Scand. J. Clin. Lab. Invest. 48:215-21
15. Brody JE. 1995. Preventing birth defects even before pregnancy. The New York Times June 28:C10
16. Brody T. 1991. Folic acid. In Handbook of Vitamins, ed. LJ Machlin, pp. 453-89. New York: Marcel Dekker. 2nd ed.
17. Butterworth CE, Baugh CM, Krumdieck C. 1969. A study of folate absorption and metabolism in man utilizing carbon-14 labeled polyglutamates synthesized by the solid phase method. J. Clin. Invest. 48:1131-42
18. Butterworth CE Jr, Santini R, Frommeyer WB. 1963. The pteroylglutamate components of American diets as determined by chromatographic fractionation. J. Clin. Invest. 42:1929-39
19. Butterworth CE Jr, Tamura T. 1989. Folic acid safety and toxicity: a brief review. Am. J. Clin. Nutr. 50:353-58
20. Center for Disease Control. 1991. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. Morbid. Mortal. Weekly Rep. 40:513-16
21. Center for Disease Control. 1992. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. Morb. Mortal. Wkly. Rep. 41:1-7
22. Center for Disease Control. 1995. Effectiveness in disease and injury prevention: use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. Morb. Mortal. Wkly. Rep. 44:140-42
23. Coelho CND, Weber JA, Klein NW, Daniels WG, Hoagland TA. 1989. Whole rat embryos require methionine for neural tube closure when cultured on cow serum. J. Nutr. 119:1716-25
24. Conway H. 1958. Effect of supplemental vitamin therapy on limitation of incidence of cleft lip and cleft palate in humans. Plast. Reconstr. Surg. 22:450-53
25. Czeizel AE. 1993. Controlled studies of multivitamin supplementation of pregnancy outcomes. In Maternal Nutrition and Pregnancy Outcomes, ed. CL Keen, A Bendich, CC Willhite, 678:266-75. New York: NY Acad. Sci.
26. Czeizel AE. 1993. Prevention of congenital abnormalities by periconceptional multivitamin supplementation. Br. Med. J. 306:1645-48
27. Czeizel AE. 1996. Folic acid-containing multivitamins and primary prevention of birth defects. In Preventive Nutrition, ed. A Bendich, R Deckelbaum. Totowa, NJ: Humana. In press
28. Czeizel AE, Dudas I. 1992. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N. Engl. J. Med. 327:1832-35
29. Czeizel AE, Dudas I, Metneki J. 1994. Pregnancy outcomes in a randomized controlled trial of periconceptional multivitamin supplementation. Final report. Arch. Gynecol. Obstet. 255:131-39
30. Czeizel A, Fritz G. 1989. Ethics of randomized trial of periconceptional vitamins. JAMA 262:1634 (Letter)
31. Davis BA, Bailey LB, Gregory JF, Toth J, Dean J, et al. 1995. Folic acid absorption in women with a history of a neural tube defect-affected pregnancy. FASEB J. 9:A154
32. Douglas B. 1958. The role of environmental factors in the etiology of "so-called" congenital malformations. Plast. Reconstr. Surg. 22:94-108
33. Duff EMW, Cooper ES, Danbury CM, Johnson BE, Serjeant GR. 1991. Neural tube defects in hurricane aftermath. Lancet 337:120-21
34. Essien FB, Wannberg SL. 1993. Methionine but not folinic acid or vitamin B-12 alters the frequency of neural tube defects in Axd mutant mice. J. Nutr. 123:27-34
35. Gardiki-Kouidou P, Seller MJ. 1988. Amniotic fluid folate, vitamin B12 and transcobalamins in neural tube defects. Clin. Genet. 33:441-48
36. Hale F. 1933. Pigs born without eye-balls. J. Hered. 24:105-6
37. Hall MH. 1972. Folic acid deficiency and congenital malformation. J. Obstet. Gynecol. 79:159-61
38. Herbert VD, Colman N. 1988. Folic acid and vitamin B12. In Modern Nutrition in Health and Disease, ed. ME Shils, VR Young, pp. 388-416. Philadelphia: Lea & Febiger
39. Hibbard BM. 1964. The role of folic acid in pregnancy - with particular reference to anaemia, abruption and abortion. J. Obstet. Gynaecol. Br. Commonw. 71:529-42
40. Hibbard ED, Smithells RW. 1965. Folic acid metabolism and human embryopathy. Lancet 1:1254
41. Keen C, Bendich A, Willhite C, eds. 1993. Maternal Nutrition and Pregnancy Outcome V. 678. New York: Ann. NY Acad. Sci.
42. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, et al. 1993. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q. J. Med. 86:703-8
43. 14C folic acid, with observations on the effect of diphenylhydantoin administration. Am. J. Clin. Nutr. 31:88-93
44. Lanoue L, Sulik KK. 1995. Homocysteine-induced embryotoxicity is ameliorated by superoxide dismutase (SOD) in whole embryo culture. FASEB J. 9:A551
45. Laurence KM, James N, Miller M, Campbell H. 1980. Increased risk of recurrence of neural tube defects to mothers on a poor diet and possible benefits of dietary counseling. Br. Med. J. 281:1542
46. Laurence KM, James N, Miller MH, Tennant GB, Campbell H. 1981. Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Br. Med. J. 282:1509-11
47. Lemire RJ. 1988. Neural tube defects. JAMA 259:558-62
48. Li D-K, Daling JR, Mueller BA, Hickok DE, Fantel AG, et al. 1995. Periconceptual multivitamin use in relation to the risk of congenital urinary tract anomalies. Epidemiology 6:211-18
49. Lucock MD, Wild J, Schorah CJ, Levene MI, Hartley R. 1994. The methylfolate axis in neural tube defects: in vitro characterization and clinical investigation. Biochem. Med. Metab. Biol. 52:101-4
50. Magnus P, Magnus EM, Berg K. 1986. Increased levels of apotranscobalamins I and II in amniotic fluid from pregnant women with previous neural tube defect offspring. Clin. Genet. 30:167-74
51. Marsack CR, Alsop CL, Kurinczuk JJ, Bower C. 1995. Pre-pregnancy counselling for the primary prevention of birth defects: rubella vaccination and folate intake. Med. J. Aust. 162:403-6
52. Medical Research Council Vitamin Study Research Group. 1991. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 338:131-37
53. Michie CA. 1991. Neural tube defects in 18th century. Lancet 337:504 (Letter)
54. Mills JL, McPartlin JM, Kirke PN, Lee YJ, Conley MR, et al. 1995. Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet 345:149-51
55. Mills JL, Rhoads GG, Simpson JL, Cunningham GC, Conley MR, et al. 1989. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N. Engl. J. Med. 321:430-35
56. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, et al. 1989. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 262:2847-52
57. Mulinare, J. 1993. Epidemiologic associations of multivitamin supplementation and occurrence of neural tube defects. In Maternal Nutrition and Pregnancy Outcome, ed. CL Keen, A Bendich, CC Willhite, pp. 130-36. New York: NY Acad. Sci.
58. Mulinare J, Cordero JF, Erickson JD, Berry RJ. 1988. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 260:3141-45
59. Nelson-Piercy C, de Swiet M. 1995. Minimal compliance with Department of Health recommendation for routine folate prophylaxis to prevent fetal neural tube defects. Br. J. Obstet. Gynaecol. 102:171 (Letter)
60. Nevin NC, Seller MJ. 1990. Prevention of neural-tube-defect recurrences. Lancet 335:178-79
61. Olson BH, Keast DR, Saldanha LG. The contribution of ready-to-eat breakfast cereal to folate and vitamin B-12 intakes in women of childbearing years. FASEB J. 9:A185 (Abstr.)
62. Patterson BH, Block G, Rosenberger WF, Pee D, Kahle LL. 1990. Fruit and vegetables in the American diet: data from the NHANES II survey. Am. J. Public Health 80:1443-49
63. Peer LA, Gordon HW, Bernhard WG. 1964. Effect of vitamins on human teratology. Plast. Reconstr. Surg. 34:358-62
64. Pietrzik K. 1989. Folate deficiency: morphological and functional consequences. Bibl. Nutr. Diet. pp. 123-30
65. Razin A, Riggs AD. 1980. DNA methylation and gene function. Science 210:604-10
66. Schorah CJ, Smithells RW. 1991. A possible role for periconceptual multivitamin supplementation in the prevention of the recurrence of neural lube defects. In Micronutrients in Health and in Disease Prevention, ed. A Bendich, CE Butterworth Jr, pp. 263-85. New York: Marcel Dekker
67. Scott JM, Kirke PN, Weir DG. 1990. The role of nutrition in neural tube defects. Annu. Rev. Nutr. 10:277-95
68. Scott JM, McPartlin J, Molloy A, McNulty H, Halligan A, et al. 1993. Folate metabolism in pregnancy. Adv. Exp. Med. Biol. 338:727-32
69. Scott J, Weir D, Kirke P. 1995. Folate and neural tube defects. In Folate in Health and Disease, ed. L Bailey, pp. 329-60. New York: Marcel Dekker
70. Scott JM, Weir DG, Molloy A, McPartlin J, Daly L, et al. 1994. Folic acid metabolism and mechanisms of neural tube defects. Ciba. Found. Symp. 181:180-87
71. Shaw GM, Lammer EJ, Wasserman, O'Malley CD, Tolarova MM. 1995. Risks of orofacial clefts in children born to women using multivitamins containing folic acid periconceptually. Lancet 345:393-96
72. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. 1995. Periconceptual vitamin use, dietary folate, and the occurrence of neural tube defects. Epidemiology 6:219-16
73. Shaw GW, Wasserman CR, O'Malley CD. 1994. Periconceptional vitamin use and reduced risk of conotruncal and limb defects in California. Teratology 49:372 (Abstr.)
74. Smithells RW, Seller MJ, Harris R, Fielding DW, Schorah CJ, et al. 1983. Further experience of vitamin supplementation for prevention. Lancet 1:1027-31
75. Smithells RW, Sheppard S, Schorah CJ. 1976. Vitamin deficiencies and neural tube defects. Arch. Dis. Child 51:994-50
76. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, et al. 1981. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch. Dis. Child 56:911-18
77. Smithells RW, Sheppard S, Wild J, Schorah CJ. 1989. Prevention of neural tube defect recurrences in Yorkshire: final report. Lancet 498-99
78. Steegers-Theunissen RP, Boers GH, Blom HJ, Nijhuis JG, Thomas CM, et al. 1995. Neural tube defects and elevated homocysteine levels in amniotic fluid. Am. J. Obstet. Gynecol. 172:1436-41
79. Steegers-Theunissen RPM, Boers GHJ, Trijbels FJM, Eskes KAB. 1991. Neural-tube defects and derangement of homocysteine metabolism. N. Engl. J. Med. 324:199
80. Stein Z, Susser M, Gerhart S, Marolla F. 1975. Famine and Development. The Dutch Hunger Winter of 1944-45. London: Oxford Univ. Press
81. Subar AF, Block G, James LD. 1989. Folate intake and food sources in the US population. Am. J. Clin. Nutr. 50:508-16
82. Tolarova M, Harris J. 1995. Reduced recurrence of orofacial clefts after periconceptional supplementation with high-dose folic acid and multivitamins. Teratology 51:71-78
83. US Department of Agriculture. 1988. Nationwide food consumption survey, continuing survey of food intakes by individuals: Women 19-50 and their children 1-5 years, 4 days. NFCS, CSFII 86-3
84. van Aerts LAGJM, Perijs JCLM, Klaasboer HH. 1991. In vitro embryotoxicity of L-homocysteine and its amelioration by L-serine, Ch3-THF, and vitamin B12. Eur. Soc. Teratology Antwerpen (Abstr.)
85. Vergel RG, Sanchez LR, Heredero BL, Rodriguez PL, Martinez AJ. 1990. Primary prevention of neural tube defects with folic acid supplementation: Cuban experience. Prenat. Diagn. 10:149-52
86. Wald N. 1993. Folic acid and the prevention of neural tube defects. Ann. NY Acad. Sci. 678:112-29
87. Wald N, Cuckle H, Boreham J. 1980. Small biparietal diameter of fetuses with spina bifida: implications for antenatal screening. Br. J. Obstet. Gynaecol. 87:219
88. Weeks EW, Tamura T, Davis RO, Birch R, Vaughn WH, et al. 1992. Nutrient levels in amniotic fluid from women with normal and neural tube defect pregnancies. Biol. Neonat. 61:226-31
89. Werler MM, Shapiro S, Mitchell AA. 1993. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 269:1257-61
90. Winship KA, Cahal DA, Weber JCP, Griffin JP. 1984. Maternal drug histories and central nervous system anomalies. Arch. Dis. Child 59:1052-60
91. Yates JRW, Ferguson-Smith MA, Shenkin A, Guzman-Rodriguez R, White M, et al. 1987. Is disordered folate metabolism the basis for the genetic predisposition to neural tube defects? Clin. Genet. 31:279-87